Fundz

Sun Bio Pharma, Inc. reported raising $2.5 Million in an initial SEC Form D filing

PRIVATESep 09, 2019

Amount Raised

$2.5 Million

$2.5 Million sold, per SEC Form D (first sale Sep 9, 2019)

Round Type

Seed

WaconiaHealthcarePharmaceutical Manufacturing

Quick answer

Panbela Therapeutics raised $2.5 Million in a Seed round, dated September 9, 2019. Panbela Therapeutics is based in Waconia, Minnesota, United States.

How much did Panbela Therapeutics raise?
Panbela Therapeutics raised $2.5 Million in a Seed round on September 9, 2019.
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs.
Where is Panbela Therapeutics based and how big is it?
Panbela Therapeutics is based in Waconia, Minnesota, United States.
Who are the decision-makers at Panbela Therapeutics?
Fundz holds 1 contact at Panbela Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical Manufacturing around the same time

Companies in the same sectors as Panbela Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • STREAMLINE HEALTH SOLUTIONS INC. raised $9.6M on October 24, 2019.
  • Reiley Pharmaceuticals raised an undisclosed amount on October 24, 2019.
  • Avitide, Inc. raised $10M on October 23, 2019.
  • Climb Bio, Inc. raised $10M on October 23, 2019.
  • All4Cure, Inc. raised $100K (Pre-Seed) on October 23, 2019.
  • Ophidion raised $755K (Seed) on October 23, 2019.

Who to call at Panbela Therapeutics, and when

A new round usually means Panbela Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Panbela Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Panbela Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Panbela Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Panbela Therapeutics

Location

712 Vista Blvd #305

Waconia, Minnesota, United States

About

Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs. The objective of Panbela’s pipeline is the utilization of pharmacotherapies to reduce/normalize increased disease-associated polyamines using complementary pharmacotherapies. The company’s lead assets are ivospemin (SBP-101), CPP-1X, utilized alone or in combination with Sulindac (Flynpovi™) which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity. These agents target the polyamine pathway at complementary junctions which have been shown to be altered is disease. In particular, our lead assets have the potential to suppress and prevent tumor growth, enhance anti-tumor activity of other anti-cancer agents, and modulate the immune system.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Panbela Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts48 people are listed at Panbela Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Panbela Therapeutics's next move

See what Strategic adds

Panbela Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.